Disparate Biosocial Risk of Malaria andSickle Cell Disease in the United States

1. World Health Organization. Malaria fact sheet. http://www.who.int/mediacentre/factsheets/fs094/en/ (2023).

2. Rees, D. C., Williams, T. N. & Gladwin, M. T. Sickle-cell disease. Lancet 376, 2018–2031 (2010).

3. Luzzatto, L. Sickle cell anaemia and malaria. Mediterr. J. Hematol. Infect. Dis. 4, (2012).

4. Berghs, M., Ebenso, B. & Ola, B. Social determinants of severity in sickle cell disease. in Sickle Cell Disease in Sub-Saharan Africa (Routledge, 2024).

5. Varo, R., Chaccour, C. & Bassat, Q. Update on malaria. Med. Clínica Engl. Ed. 155, 395–402 (2020).

6. Tangpukdee, N., Duangdee, C., Wilairatana, P. & Krudsood, S. Malaria diagnosis: A brief review. Korean J. Parasitol. 47, 93– 102 (2009).

7. Dyson, S. Sickle Cell and the Social Sciences: Health, Racism and Disablement. (Routledge, London, 2019). doi:10.4324/9781315098685.

8. Aidoo, M. et al. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 359, 1311–1312 (2002).

9. Inikori, J. E. Measuring the Atlantic slave trade: An assessment of Curtin and Anstey. J. Afr. Hist. 17, 197–223 (1976).

10. Burnard, T. The Atlantic slave trade. in The Routledge History of Slavery (Routledge, 2010).

11. Kwiatkowski, D. P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 77, 171–192 (2005).

12. Mungai, M., Tegtmeier, G., Chamberland, M. & Parise, M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N. Engl. J. Med. 344, 1973– 1978 (2001).

13. Pokhrel, A., Olayemi, A., Ogbonda, S., Nair, K. & Wang, J. C. Racial and ethnic differences in sickle cell disease within the United States: From demographics to outcomes. Eur. J. Haematol. 110, 554–563 (2023).

14. Esoh, K. & Wonkam, A. Evolutionary history of sickle-cell mutation: Implications for global genetic medicine. Hum. Mol. Genet. 30, R119–R128 (2021).

15. Thomson, A. M. et al. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: A systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol. 10, e585–e599 (2023).

16. Makani, J., Williams, T. N. & Marsh, K. Sickle cell disease in Africa: Burden and research priorities. Ann. Trop. Med. Parasitol. 101, 3–14 (2007).

17. World Health Organization. African health ministers launch drive to curb sickle cell disease toll. WHO | Regional Office for Africa https://www.afro.who.int/news/africanhealth-ministers-launch-drive-curb-sicklecell-disease-toll (2023).

18. Tebbi, C. K. Sickle cell disease, a review. Hemato 3, 341–366 (2022).

19. Kavanagh, P. L., Fasipe, T. A. & Wun, T. Sickle cell disease: A review. JAMA 328, 57–68 (2022).

20. Monroe, A., Williams, N. A., Ogoma, S., Karema, C. & Okumu, F. Reflections on the 2021 World Malaria Report and the future of malaria control. Malar. J. 21, 154 (2022).

21. Prabhakar, H., Haywood Jr., C. & Molokie, R. Sickle cell disease in the United States: Looking back and forward at 100 years of progress in management and survival. Am. J. Hematol. 85, 346–353 (2010).

22. Manley, A. F. Legislation and funding for sickle cell services, 1972-1982. Am. J. Pediatr. Hematol. Oncol. 6, 67–71 (1984).

23. Salinas Cisneros, G. & Thein, S. L. Recent advances in the treatment of sickle cell disease. Front. Physiol. 11, 435 (2020).

24. Johnson, K. M. et al. Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance. Blood Adv. 7, 365–374 (2023).

25. Payne, A. B. et al. Trends in sickle cell disease– related mortality in the United States, 1979 to 2017. Ann. Emerg. Med. 76, S28–S36 (2020).

26. US Department of Health & Human Services, Office of Minority Health. Black/AfricanAmerican Health. https://minorityhealth.hhs.gov/blackafrican-american-health.

27. Williams, D. R. & Sternthal, M. Understanding racial/ethnic disparities in health: Sociological contributions. J. Health Soc. Behav. 51, S15–S27 (2010).

28. Dankwa-Mullan, I., Pérez-Stable, E. J., Garnder, K. L., Zhang, X. & Rosario, A. M. The Science of Health Disparities Research. (John Wiley & Sons, Incorporated., 2021).

29. Jenerette, C., Funk, M. & Murdaugh, C. Sickle cell disease: A stigmatizing condition that may lead to depression. Issues Ment. Health Nurs. 26, 1081–1101 (2005).

30. Elander, J., Beach, M. C. & Haywood Jr, C. Respect, trust, and the management of sickle cell disease pain in hospital: Comparative analysis of concern-raising behaviors, preliminary model, and agenda for international collaborative research to inform practice. Ethn. Health 16, 405–421 (2011).

31. Brennan-Cook, J., Bonnabeau, E., Aponte, R., Augustin, C. & Tanabe, P. Barriers to care for persons with sickle cell disease: The case manager’s opportunity to improve patient outcomes. Prof. Case Manag. 23, 213 (2018).

32. Hood, A. M. et al. The influence of perceived racial bias and health-related stigma on quality of life among children with sickle cell disease. Ethn. Health 27, 833–846 (2022).

33. Naik, R. P. & Haywood, C. Sickle cell trait diagnosis: clinical and social implications. Hematol. Am. Soc. Hematol. Educ. Program 2015, 160–167 (2015).

34. Nixon, R. Statement on signing the national sickle cell anemia control act.

35. National Center for Science and Engineering Statistics (NCSES). Diversity and STEM: Women, Minorities, and Persons with Disabilities 2023. https://ncses.nsf.gov/wmpd (2023).

36. Jones, N., Marks, R., Ramirez, R. & Rios- Vargas, M. 2020 census illuminates racial and ethnic composition of the country. Census.gov https://www.census.gov/library/ stories/2021/08/improved-race-ethnicity- measures-reveal-united-states-population- much-more-multiracial.html (2021).

37. Schroeder, W., A., Munger, E. S. & Powers, D. R. Sickle cell anaemia, genetic variations, and the slave trade to the United States. J. Afr. Hist. 31, 163–180 (1990).

38. Tubman, V. N., Mohandas, N. & Abrams, C. S. New ASH initiatives to improve patient care in the long-overlooked sickle cell disease. Blood 142, 230–234 (2023).